Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0457
+0.0065 (16.58%)
At close: Feb 6, 2026
Carisma Therapeutics Revenue
Carisma Therapeutics had revenue of $45.25M in the quarter ending September 30, 2025, with 1,236.78% growth. This brings the company's revenue in the last twelve months to $52.63M, up 159.68% year-over-year. In the year 2024, Carisma Therapeutics had annual revenue of $19.63M with 31.59% growth.
Revenue (ttm)
52.63M
Revenue Growth
+159.68%
P/S Ratio
0.03
Revenue / Employee
1.14M
Employees
46
Market Cap
1.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.63M | 4.71M | 31.59% |
| Dec 31, 2023 | 14.92M | 5.09M | 51.71% |
| Dec 31, 2022 | 9.83M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCarisma Therapeutics News
- 2 months ago - Carisma Therapeutics (CARM) Plans Nasdaq Delisting and SEC Deregistration - GuruFocus
- 2 months ago - Carisma Announces Delisting from Nasdaq and SEC Deregistration - PRNewsWire
- 7 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, CARM, ENZB on Behalf of Shareholders - GlobeNewsWire
- 8 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders - PRNewsWire
- 8 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE and CARM on Behalf of Shareholders - PRNewsWire
- 8 months ago - CARM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Carisma Therapeutics Inc. Is Fair to Shareholders - Business Wire
- 11 months ago - Carisma Therapeutics Provides Corporate Updates - PRNewsWire
- 1 year ago - Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - PRNewsWire